Skip to main content
RAPS 2024 Regulatory Intelligence Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Linda F. Bowen, MSc, FRAPS

Chief of Staff, Oncology Global Regulatory Strategy
Pfizer, United States

Linda has 40 years-experience in the BioPharma Industry, of which 30 years were spent in regulatory strategy, intelligence and policy roles. She is Chief of Staff, Business Operations and Integration Lead, for the newly formed Pfizer Oncology R&D, Regulatory Strategy group. She was previously Chief of Staff and Head of the Regulatory Centers of Excellence at Seagen, Inc., and has held senior regulatory positions at Sanofi, Bayer and GSK.

She has also been an adjunct in the Temple RAQA Master's Program since 1998.

She attained regulatory affairs certification for the US, Canada, and Europe, and was an inductee to the 2011 Class of RAPS Fellows. Linda was honored with the Drug Information Association's 2012 Excellence in Volunteer Leadership, the 2019 Americas Inspire Awards, and the 2022 Global Inspire Award - Community Engagement as well as the RAPS 2020 Founder’s Award.

She is a past two-term member of the RAPS Board of Directors and is current Chair of the Industry (Affiliate) Board, as well as immediate past chair of the NJ/NY RAPS Chapter. Linda previously chaired the DIA Regulatory Affairs Community (2012-2023) and founded the DIA Regulatory Intelligence Working Group (2006). She sat on the planning committees for 2013-2017 DIA Annual Conference, the 2011-2017 RAPS Annual Convergence and was Program Chair for the 2018 & 2019 RAPS Annual Convergence.

She is most proud of her role as educator and mentor to those entering the regulatory profession.

Disclosure information not submitted.

Presentation(s):